Is hepatitis B curable?
79239
No. They can give you medicine to the point where you may not feel symptoms but the hepatitis will always remain in your liver.
839606
Hi check with your doctor, has your wife been vaccinated for Hep B? If not might be a good idea to have her vaccinated. I have included some info for you and some links to look at if you wish.\n\nGood luck and take care.\n\nHepatitis B - the facts\n\nThere are several viruses that can cause hepatitis and each virus is known by a letter in the alphabet, such as hepatitis B. All of the viruses cause similar problems, but they are spread in different ways. \n\nSymptoms of hepatitis B\nSome people have no symptoms at all, but for others the symptoms may include: \n\n*Loss of appetite, nausea and vomiting. \n*Pain in the liver - this is felt under the right hand side of the ribcage. \n*Fever. \n*Pain in the joints. \n*Jaundice - the urine becomes darker and the eyes and skin turn yellow. \n*Tiredness.\nHow hepatitis B is spread\nHepatitis B can be spread by: \n\n*Having sexual intercourse without a condom. \n*Sharing needles, syringes and other injecting equipment. \n*Sharing razor blades and toothbrushes. \n*Piercing the skin with improperly cleaned and sterilised equipment. \n*Infected blood coming into contact with the open cuts of an uninfected person.\nHepatitis B can also be passed from an infected mother to a baby before or after birth. Giving babies hepatitis B vaccine when they are born will help protect them from the disease. . \n\nChronic carriers\nAlthough most people who catch hepatitis B recover completely and no longer have the virus in their bodies, some people have the virus in their bodies for their whole lives. These people are ‘carriers’. Approximately 10 per cent of adults and 90 per cent of children who are infected with hepatitis B will become chronic carriers of the disease. These people often show no symptoms but they can infect others, even when they look and feel well. Carriers may eventually develop liver cancer or chronic liver disease.\n\nProtecting yourself against hepatitis B\nTo help protect yourself against hepatitis B: \n\n*Get immunised with hepatitis B vaccine. \n*Use condoms for vaginal or anal sex. \n*Oral sex is normally unlikely to spread hepatitis B, however, it is best to avoid oral sex if you or your partner has herpes, ulcers or bleeding gums. \n*Do not share needles, syringes or other equipment (such as spoons, swabs and water) if you inject drugs. \n*Wear disposable gloves when cleaning up blood or administering first aid.\nIf you think you have been exposed to hepatitis B, see your doctor immediately. You can be given treatment that may greatly reduce the risk of infection.\n\nYou can be immunised against hepatitis B\nYou need three injections to be fully immunised: \n\n*The first two injections are given one month apart. \n*The third injection is given five months after the second dose.\nIf you started the course of vaccinations but did not finish them you do not need to start again, just complete the other doses.\n\nSide-effects are uncommon, but can occur soon after immunisation. They include fever, soreness at the injection site, nausea and joint pain.\n\nSome people can be immunised for free\nHepatitis B immunisation is free for: \n\n*All students in Year 7 at school. \n*All babies born after 1 May 2001. \n*Children up to ten years old who live in a household with a carrier. \n*Children up to ten years old who belong to a population group that is known to have a high carrier rate. \n*Injecting drug users via a needle and syringe program where there is a doctor or nurse vaccinator on site or from a methadone provider.\nWho should be immunised\nImmunisation is recommended for everyone and especially for: \n\n*Injecting drug users. \n*Health workers and others who come in contact with blood during their work. \n*Workers (and residents) at facilities for people with an intellectual disability. \n*Sexually active people. \n*People with other medical conditions - for example, people with other forms of hepatitis or liver disease or people who receive medical treatment with blood pr
1157207
yes, you were infected at some point with the hep C virus. It is possible for hep C to resolve on it's own occasionally. This is very rare compared to hep B which often resolves without becoming chronic.  I know one guy whose hep c resolved without treatment and has antibodies but no infection. In this case you would be viral negative but test positive for the antibodies. If I was in your shoes I would get retested every 6 months for the next couple of years unless a very smart hepatologist or gastroenterologist could explain to me why the testing wasn't necessary.  \n\nhttp://www.webmd.com/hw/hepatitus_c/tw9921.asp
1170207
Did you mean: chronic hep b?\n\nHepatitis B: Formally known as serum hepatitis Hep b is transmitted via sexual contact, saliva, contaminated needles used by drug users and exposure to infected blood. Hep B often will progress to a chronic hepatitis without showing signs of active hepatitis. The risk of contracting Hep B can be reduced with a series of vaccines.\n\nChronic hepatitis persists for long periods of time and is classified as either chronic persistent or chronic acute. Chronic persistent hepatitis is usually mild and slow to progress. However, it can become more severe, progressing to chronic acute hepatitis. As liver damage becomes more extensive and severe, chronic active hepatitis can cause cirrhosis, most often resulting in liver failure and even death.\n\nOr did you mean Herpes? \n\nGenital herpes is a sexually transmitted disease (STD) caused by the herpes simplex viruses type 1 (HSV-1) and type 2 (HSV-2). Most genital herpes is caused by HSV-2. Most individuals have no or only minimal signs or symptoms from HSV-1 or HSV-2 infection. When signs do occur, they typically appear as one or more blisters on or around the genitals or rectum. The blisters break, leaving tender ulcers (sores) that may take two to four weeks to heal the first time they occur. Typically, another outbreak can appear weeks or months after the first, but it almost always is less severe and shorter than the first outbreak. Although the infection can stay in the body indefinitely, the number of outbreaks tends to decrease over a period of years.
602184
for hepa A u need to be vaccinated again it is cureable but it will stay in ur body ... hepa b is not cureable and it can also infect anybody ...........
187693
Curable STD.\nLook here:
738760
Nope.. TB is curable.\n\nOnce cured, you will not fail the medical exam.
109374
If you do not see any side effects count your blessings. We still do not know if that is the reason our 8 year old son (developmentall under 1) Has the problems he has. He is adopted and his mother tested hep B positive at birth so he was given I belive 2 mega hep B vacines plus I think a regular one also.
506239
Hepatitis B surface antigen (HBsAg) is one of the most frequently performed tests for HBV. This HBV antigen is the earliest indicator of an active hepatitis B infection. This antigen may be present before symptoms of an HBV infection are present. If this antigen level remains high for more than 6 months, then you will probably become a carrier of HBV, meaning you can transmit it to others throughout your life. \nHepatitis B surface antibody (HBsAb) is also one of the most common tests for HBV. Usually this antibody appears about 4 weeks after HBsAg disappears and means that the infection is at the end of its active stage and you cannot pass the virus to others (you are no longer contagious). This antibody also protects you from getting HBV again in the future. The test is done to determine the need for vaccination; the antibody will be present after receiving the HBV vaccine series, showing that you have protection (immunity) from the virus. Occasionally your test may show that you have both the HBsAb and HBsAg antibodies; in this case, you are still contagious. \nHepatitis B core antigen (HBcAg). Currently, there is no test to find this antigen. \nHepatitis B core antibody (HBcAb) is an antibody to the hepatitis B core antigen. This antibody appears about 1 month after an active HBV infection. It can be found in people who had an infection in the past and in those with long-term (chronic) HBV. It usually is present for life. \nHepatitis B core antibody IgM (HBcAbIgM) is also an antibody to the hepatitis B core antigen. It shows a recent infection in the last 6 months. \nHepatitis B e-antigen (HBeAg) is an HBV protein that is only present during an active HBV infection. This test determines how contagious you are. Testing for this antigen can also be used to monitor the effectiveness of treatment for HBV. \nHepatitis B e-antibody (HBeAb) shows that the active stage of the HBV infection is almost over and your risk of being contagious is greatly reduced. HBeAb is usually present during chronic HBV infections. \nHBV DNA testing finds genetic material (DNA) from the hepatitis B virus. Currently, quantitative HBV DNA tests are done. A high HBV DNA level means that the virus is multiplying in your body and you are very contagious. If you have a chronic HBV infection, an elevated viral DNA level means you are at an increased risk for chronic hepatitis and may want to consider treatment with medications. Testing for HBV DNA also is important to monitor the effectiveness of treatment for chronic HBV infection. HBV DNA testing is a more sensitive test than HBeAg (above) for detecting HBV in the blood
575342
There are currently several treatments for chronic hepatitis B that can increase a person's chance of clearing the infection. Treatments are available in the form of antivirals such as lamivudine and adefovir and immune system modulators such as interferon alpha. There are several other antivirals under investigation. Roughly, all of the currently available treatments, when used alone, are about equally efficacious. However, some individuals are much more likely to respond than others. It does not appear that combination therapy offers any advantages.[4] In general, each works by reducing the viral load by several orders of magnitude thus helping a body's immune system clear the infection. Treatment strategies should be individualized by a doctor and patient. Considerations include the risks associated with each treatment, a person's likelihood of clearing the virus with treatment, a person's risk for developing complications of persistent infection, and development of viral resistance with some of the treatments.\n\nOn March 29, 2005, the US FDA approved Entecavir for the treatment of hepatitis B.\n\nOn February 25, 2005, the EU Commission approved PEGASYS for the treatment of hepatitis B making it the first pegylated interferon to be approved for hepatitis B.\n\nChronic carriers should be strongly encouraged to avoid consuming alcohol as it increases their risk for cirrhosis and hepatocellular carcinoma (liver cancer).\n\nInfants born to mothers known to carry hepatitis B can be treated with antibodies to the hepatitis B virus (hepatitis B immune globulin or HBIg). When given with the vaccine within twelve hours of birth, the risk of acquiring hepatitis B is reduced 95%. This treatment also allows a mother to safely breastfeed her child.\n\nAn individual exposed to the virus who has never been vaccinated may be treated with HBIg immediately following the exposure. For instance, a health care worker accidentally stuck by a needle used in a hepatitis B carrier would qualify. Treatment must be soon after exposure, however.
547137
I don't really know much about Hepatitis A and B but I do know that they treat Hepatitis C with interferon.  It usually consists of 1 shot a weeks and Ribavirin pills daily.  Some people do treatment for 24 weeks and some do 48 weeks, depending on your genotype (the strain of the virus). Treatment can be very tough for alot of people.  You have to eat right, drink 1/2 your weight of water and get plenty of rest.  Alot of people have to get on antidepressant before treatment as it can cause depression in alot of people. Some people work or go to school while doing treatment and some are not able to.  You are monitored while you are on treatment with regular blood tests to make sure you are doing okay while on treatment.  I don't really know if there is a cure.  This is very controversial as some doctors say there is a cure and some say it just goes into remission.
175385
You'll need to get on a strict diet.  No salt or alot of proteins.  Hepatitis C is not curable.  You will sooner or later have to have a transplant if it gets worse and that's not necessarily exactly the end of the H-C.  Stay away from alcohol for sure.  No drugs.  Since it's not to scarred, that's good but you'll want to make sure it doesn't get that way so that's why I suggest the diet part.  I have cryptogenic liver disease and I have alot of swelling daily. If you're not swelling, just stay away from the harmful things that your liver would have to filter out.  I think it's all about the intake of fluids and foods and certain medications.  If you can do all of that, it will slow the scarring process down.
39766
It depends upon your age and immune function.\n\nChildren are very unlikely to clear the HBV infection if they are born to mothers with HBV. In fact, only about 10% clear the infection and 90% develop chronic HBV. These individuals typically begin to have complications, including liver inflammation, fibrosis, cirrhosis, and liver cancer earlier in life (20's to 30's)\n\nAdults infected with HBV are more likely to clear the infection.  Approximately 90% of adults will clear the infection (often after several months of symptoms, including jaundice) while only about 10% will develop chronic HBV.\n\nThere is a vaccine and it is now recommended that children be vaccinated so hopefully this will be a distant memory in another 20-30 years.
622828
Homeopathically Speaking, Yes its definatelly curable !\nWith what ? \nFor that I need your specific individual details and your medical history ! post details and i will post your remedy ! No Side effects no complications just relief !\nTake care and God Bless !
172091
Bed bugs ( Cimex lectularius) can possibly transmit Hepatitis B.
797389
mcc_md@yahoo.com for more info\n\nThere is no specific treatment for acute hepatitis B; in 95 percent of adults, the immune system controls the infection and eliminates the virus within about six months. In people who develop chronic hepatitis, the goals of treatment are to stop the virus from multiplying while liver damage is still reversible.\n\nGeneral measures — All persons infected with chronic hepatitis B should be vaccinated against hepatitis A unless they are already known to be immune. Pneumococcal vaccine and yearly influenza vaccination should be considered in patients who have developed cirrhosis.\n\nRegular screening for liver cancer is also recommended, particularly for older individuals, those with cirrhosis, and patients with family history of liver cancer. In general, this entails an annual or biannual ultrasound examination and blood test for serum alpha fetoprotein level (a protein frequently produced by liver tumors, which is detectable in blood). The best approach to screening for liver cancer has not been determined.\n\nAntiviral therapy — Four currently available drugs slow or stop multiplication of the hepatitis B virus: lamivudine, adefovir, entecavir and interferon-alpha. Not all hepatitis B patients will benefit from approved treatments. The physician and the patient should discuss treatment options after a careful assessment of the individual's conditions. Regular monitoring is needed during treatment to assess for response, side effects and drug resistance, and for relapse after treatment is stopped. Regular monitoring is also needed if treatment is deferred, as some patients may benefit from treatment when the hepatitis becomes more active later on.\n\nLamivudine — Lamivudine (Epivir-HBV) is a good first treatment for people with chronic hepatitis B who have detectable virus activity and ongoing liver inflammation. Lamivudine is also appropriate for people who have had a poor response to interferon-alpha, people who have worsening cirrhosis, and people who experience sudden liver failure.\n\nStudies suggest that long-term treatment with lamivudine (treatment for at least one year) decreases virus levels and reduces inflammation of the liver.\n\nLamivudine is taken orally, usually at a dosage of 100 mg/day, for at least one year. Although it is very safe, the drug can trigger a flare of hepatitis in some people and can also be associated with uncommon side effects that you should discuss with your doctor. The major problem with lamivudine is that a resistant form of hepatitis B virus (referred to as a YMDD mutant) frequently develops in patients on long-term treatment. Appearance of the mutant virus may be accompanied by a marked increase in virus level and a flare of hepatitis, and in rare instances liver failure. As new drugs with lower rates of drug resistance become available, lamivudine is used less commonly in patients who require long-term treatment.\n\nAdefovir — Adefovir (Hepsera) is an alternative initial choice for people who have detectable virus activity and ongoing liver inflammation. An advantage of adefovir compared to lamivudine is that resistance to the drug occurs at much lower rates. In addition, adefovir can suppress lamivudine- resistant hepatitis B mutants. Adefovir has been associated with kidney problems when used in high doses or for long durations, so kidney function needs to be checked before and during treatment.\n\nAdefovir is taken orally, at a dosage of 10 mg/day, for at least one year. Most patients will need long-term treatment to maintain control of the hepatitis B virus.\n\nEntecavir — Entecavir (Baraclude) is another choice for people who have detectable virus activity and ongoing liver inflammation. It is a relatively new drug so its benefits and safety are still being determined. An advantage compared with lamivudine and adefovir is its greater potency against the hepatitis B virus. So far, resistance seems to be very rare. A disadvantage is its
734617
If you Are ONLY HBsAb+, then Immune and No Chronic Infection.  But you Said HBsAg+, Possibly Primary or Chronic Infection, Inquire of your Dr. About Meds. for this.